Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-05

Clinical Trial Update: An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder [Phase 4]

View source ↗

Summary

Open-label Phase 4 pilot study evaluating adjunctive asenapine for treatment of posttraumatic stress disorder; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)

Snippet

Sponsor: Lori Davis, MD | Conditions: Posttraumatic Stress Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-12-05